title: Cardiopulmonary toxicity after liposomal amphotericin B infusion.
authors.affiliation: National Institutes of Health, Bethesda, Maryland.
authors.forename: S J
authors.initials: SJ
authors.lastname: Levine
authors.forename: T J
authors.initials: TJ
authors.lastname: Walsh
authors.forename: A
authors.initials: A
authors.lastname: Martinez
authors.forename: P Q
authors.initials: PQ
authors.lastname: Eichacker
authors.forename: G
authors.initials: G
authors.lastname: Lopez-Berestein
authors.forename: C
authors.initials: C
authors.lastname: Natanson
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage* / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004337:Drug Carriers; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D008081:Liposomes; D008168:Lung / Q000098:blood supply; D008171:Lung Diseases / Q000139:chemically induced* / Q000503:physiopathology; D011659:Pulmonary Gas Exchange / Q000187:drug effects
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D000666:Amphotericin B